Glatopa FDA Approval History
FDA Approved: Yes (First approved April 16, 2015)
Brand name: Glatopa
Generic name: glatiramer acetate
Dosage form: Injection
Company: Sandoz Inc.
Treatment for: Multiple Sclerosis
Glatopa (glatiramer acetate) is a generic version of Copaxone, an immunomodulator drug for the treatment of patients with relapsing-forms of multiple sclerosis.
Development timeline for Glatopa
|Apr 16, 2015||Approval FDA Approves Glatopa (glatiramer acetate) as the First Generic Competitor to Copaxone|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.